Mednet Logo
HomeMedical Oncology
Medical Oncology

Medical Oncology

Physician insights on cancer treatment protocols, immunotherapy, targeted therapies, and clinical trial updates.

Recent Discussions

How would you approach a primary small cell carcinoma of the vagina in a patient with an intact uterus and cervix?

1 Answers

Mednet Member
Mednet Member
Radiation Oncology · Varian Medical Systems/Allegheny health network

We treat with the same principle as cervical small cell with combination of concurrent chemo with cis and RT (EBRT plus brachy) followed by adjuvant cis and etoposide. No pCI.

How would you treat locally advanced melanoma of the scalp with several in transit lesions and a metastatic lesion to the parotid if the patient is progressing on immunotherapy such as pembrolizumab?

1 Answers

Mednet Member
Mednet Member
Radiation Oncology · Memorial Sloan Kettering Cancer Center

I think it is important to first define whether this is truly primary progression or whether the patient may have a delayed response. The Society for Immunotherapy of Cancer (SITC) has some consensus guidelines for defining this:Kluger et al., PMID 32238470 It is important to recognize that these ar...

How would you treat a patient with muscle invasive urothelial carcinoma with squamous differentiation?

1
1 Answers

Mednet Member
Mednet Member
Medical Oncology · AdventHealth Cancer Institute

In general, pure and predominant urothelial carcinoma (majority or >50% of tumor consisting of urothelial carcinoma) have been treated similarly at least in trials. Patients with predominant or pure non-urothelial histology have typically not been enrolled in trials of urothelial carcinoma. There ar...

What is the appropriate RT dose for an advanced stage follicular lymphoma?

2
2 Answers

Mednet Member
Mednet Member
Radiation Oncology · Varian Medical Systems/Allegheny health network

Based on the study for patients of early stage low grade lymphoma treated with curative intent, the dose should be 24 Gy.For those treated with palliative intent, 2gy x2 should be preferred, as the majority have good palliation with that dose. In the minority where symptoms persists, one can treat a...

How long would you wait after a cycle of IT MTX to treat a spinal lesion causing cord compression in a patient with stage IV DLBCL?

1 Answers

Mednet Member
Mednet Member
Radiation Oncology · The Oregon Clinic-Radiation Oncology West

Intrathecal methotrexate has biphasic half-lives of about 5 hours and 14 hours (Bleyer, Cancer Treat Rep 1977). ILROG recommends typically waiting minimum interval 2 weeks between last IT or high-dose IV methotrexate before starting CNS radiotherapy for CNS leukemia, but urgent radiotherapy may be c...

Do you utilize tumor treating fields in patients with anaplastic pleomorphic xanthoastrocytoma (PXA) III?

1 Answers

Mednet Member
Mednet Member
Medical Oncology · Stanford University School of Medicine

I would, but I haven't actually had the opportunity. With more information appearing that TTF is effective in brain metastases, mesothelioma, and pancreatic cancer, why wouldn't you use it if you didn't have a better option? The only real risk is financial.

How would you approach surveillance imaging for men with early-stage, hormone receptor-positive breast cancer after unilateral mastectomy?

3
2 Answers

Mednet Member
Mednet Member
Medical Oncology · Avita Health System

As always, appreciate others' input. If you're referring to systemic imaging, I do not obtain surveillance systemic imaging as part of surveillance for any patient with early-stage hormone-positive breast cancer (male or female) unless there are symptoms or initial labs that suggest possible metasta...

When a patient with pancreatic cancer received neoadjuvant chemo + chemo-RT, how do you manage an in-field, post operative positive margin?

1
3 Answers

Mednet Member
Mednet Member
Radiation Oncology · Memorial Sloan-Kettering Cancer Center

The data from MD Anderson indicates that patients have a similar survival duration when they have an R1 resection after chemoradiation as when they have an R0 resection, and longer than expected with a positive margin. The Mayo Clinic also has data in rectal cancer where there may be an increased ri...

Do you routinely repeat imaging for PE after anticoagulation treatment to establish a new baseline?

1
2 Answers

Mednet Member
Mednet Member
Medical Oncology · Ohio State University

We only do imaging if the patient is symptomatic still after a few weeks or has persistent chest pain or clinical signs of pulmonary hypertension. Rarely I have seen recurrent or progressive thromboembolic disease on anticoagulation. Another possible reason if the patient needs to go to surgery in t...

In which situations do you omit the 5FU bolus in FOLFOX or FOLFIRI?

3
2 Answers

Mednet Member
Mednet Member
Medical Oncology · Mayo Clinic

This is a very commonly asked question in the clinic.The original studies all included leucovorin (LV) and bolus 5Fu as part of the regimen (FOLFOX, FOLFIRI). However, in the clinic, we know that the 5Fu bolus is the main reason that this patient has significant cytopenia and worse side effects from...